CVS to pay $315M over opioid case

CVS Pharmacy and its subsidiaries have agreed to pay $315 million to settle a Justice Department lawsuit alleging they unlawfully dispensed large quantities of addictive opioids without proper medical oversight. The lawsuit, filed in 2024 under the Biden administration, accused CVS of violating the Controlled Substances Act by filling prescriptions from illegitimate sources, often driven by staffing issues and incentive policies. The settlement requires CVS to implement additional safeguards to ensure opioids are prescribed only when appropriate.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل